Proteomic Profiling in Multiple Sclerosis Clinical Courses Reveals Potential Biomarkers of Neurodegeneration
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proteomic Profiling in Multiple Sclerosis Clinical Courses Reveals Potential Biomarkers of Neurodegeneration
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 8, Pages e103984
Publisher
Public Library of Science (PLoS)
Online
2014-08-07
DOI
10.1371/journal.pone.0103984
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Converging Pathways of Chromogranin and Amyloid Metabolism in the Brain
- (2017) Niklas Mattsson et al. JOURNAL OF ALZHEIMERS DISEASE
- Naive CD4 T-cell activation identifies MS patients having rapid transition to progressive MS
- (2014) E. Zastepa et al. NEUROLOGY
- Thymosin beta 4 gene silencing decreases stemness and invasiveness in glioblastoma
- (2013) Hans-Georg Wirsching et al. BRAIN
- Cerebrospinal Fluid Levels of Soluble Amyloid Precursor Protein and β-Amyloid 42 in Patients with Multiple Sclerosis, Neuromyelitis Optica and Clinically Isolated Syndrome
- (2013) W Mai et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Onset of secondary progressive phase and long-term evolution of multiple sclerosis
- (2013) A. Scalfari et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients
- (2013) Giulio Disanto et al. Multiple Sclerosis Journal
- Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome
- (2013) Gijsbert JA Nagtegaal et al. Multiple Sclerosis Journal
- Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis
- (2013) Charlotte Teunissen et al. Multiple Sclerosis Journal
- Gray Matter Is Targeted in First-Attack Multiple Sclerosis
- (2013) Steven E. Schutzer et al. PLoS One
- Fluctuations of MS births and UV-light exposure
- (2012) F. Verheul et al. ACTA NEUROLOGICA SCANDINAVICA
- Treatment of neurological injury with thymosin β4
- (2012) Daniel C. Morris et al. Annals of the New York Academy of Sciences
- Contribution of Cerebrospinal Fluid Thymosin β4 Levels to the Clinical Differentiation of Creutzfeldt-Jakob Disease
- (2012) Maria Le Pera et al. ARCHIVES OF NEUROLOGY
- The Neuroendocrine Protein 7B2 Suppresses the Aggregation of Neurodegenerative Disease-related Proteins
- (2012) Michael Helwig et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Association between pathological and MRI findings in multiple sclerosis
- (2012) Massimo Filippi et al. LANCET NEUROLOGY
- Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome
- (2012) Giancarlo Comi et al. Multiple Sclerosis Journal
- Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis
- (2012) Laura F. Dagley et al. Proteomics Clinical Applications
- Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation
- (2012) Dimitrios Davalos et al. Nature Communications
- Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci
- (2011) Nikolaos A. Patsopoulos et al. ANNALS OF NEUROLOGY
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Proteomic pattern analysis discriminates among multiple sclerosis-related disorders
- (2011) Mika Komori et al. ANNALS OF NEUROLOGY
- Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis
- (2011) Ajit Singh Dhaunchak et al. ANNALS OF NEUROLOGY
- Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica
- (2011) C. Tortorella et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Unknown
- (2011) Carla Jennewein et al. MOLECULAR MEDICINE
- Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry
- (2011) CE Teunissen et al. Multiple Sclerosis Journal
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
- (2011) Stephen Sawcer et al. NATURE
- Natural History of Multiple Sclerosis: Have Available Therapies Impacted Long-Term Prognosis?
- (2011) Maria Trojano et al. NEUROLOGIC CLINICS
- Quantification of thymosin β4 in human cerebrospinal fluid using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
- (2010) Elena Urso et al. ANALYTICAL BIOCHEMISTRY
- Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis
- (2010) Manuel Comabella et al. BRAIN
- Proteomic profiling of cerebrospinal fluid in Creutzfeldt–Jakob disease
- (2010) Antonio Qualtieri et al. Expert Review of Proteomics
- Proteomics Comparison of Cerebrospinal Fluid of Relapsing Remitting and Primary Progressive Multiple Sclerosis
- (2010) Marcel P. Stoop et al. PLoS One
- Downregulation of thymosin 4 in neural progenitor grafts promotes spinal cord regeneration
- (2009) C. Mollinari et al. JOURNAL OF CELL SCIENCE
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
- (2009) C. E. Teunissen et al. NEUROLOGY
- Neurological functional recovery after thymosin beta4 treatment in mice with experimental auto encephalomyelitis
- (2009) J. Zhang et al. NEUROSCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started